DeutschNewstral
Article
The Times of India on 2022-01-05 22:48
Molnupiravir has serious safety concerns: ICMR chief
Related news
- India’s managed to ‘distribute’ curve: ICMR chiefThe Times of India
- When should you take your covid test? ICMR chief revealsThe Times of India
Most of India should remain locked down for 6-8 weeks: ICMR chiefThe Hindu- Covaxin development has proved India is more than pharmacy of world: ICMR chiefThe Hindu
- Coronavirus | Cases rising in 15 States; positivity rate at 21%, says ICMR chiefThe Hindu
Merck’s COVID-19 pill could carry serious safety concerns, scientists warnFox News- Coronavirus | ICMR completes second sero-surveyThe Hindu
- Coronavirus | Negligence could lead to reinfection: ICMRThe Hindu
- ICMR to get royalty from Covaxin saleThe Hindu
- Coronavirus | Cases surge; ICMR denies community transmissionThe Hindu
- Bid to fast-track vaccine development: ICMRThe Times of India
- Most Indians still susceptible to Covid: ICMRThe Times of India
- All adults need Covid-19 booster dose, says chief of top ICMR bodyThe Times of India
- Coronavirus | Small fraction of those vaccinated get infected, says ICMRThe Hindu
- ICMR plans new survey to estimate COVID-19 spreadThe Hindu
- Coronavirus | Children could be spreaders or super-spreaders, says ICMRThe Hindu
- Half of studied Omicron cases in India fully vaccinated: ICMRThe Hindu
- Covid: ICMR sits on proposal to try arthritis drugThe Times of India
- Over 21% Indians exposed to COVID-19, says ICMR serosurveyThe Hindu
- Coronavirus | Very few post-vaccine infections, says ICMRThe Hindu